Review
Jul 2026
Targeting the NLRP3 Inflammasome in Alzheimer's Disease: Mechanistic Insights and Therapeutic Advances.
This review regards NLRP3 inflammasome as a critical inflammatory hub and a promising target for disease-modifying therapy in AD, and provides useful perspectives on AD pathogenesis to inform the development of more rational therapeutic strategies.
Wenwen Lian, Fulin Zhou, Zhuohang Tong et al.
· Ageing Research Reviews · 0 citations